Company Overview - Bristol-Myers Squibb Company is currently led by CEO Chris Boerner, who has been in the role since November 2023 [5] - The company is focusing on emerging as one of the fastest-growing firms in the pharmaceutical sector, particularly in light of several upcoming loss of exclusivity (LOE) events [5] Industry Context - The timing of the conference is significant due to various ongoing developments within the pharmaceutical industry [4] - The company aims to navigate challenges and capitalize on opportunities presented by the evolving landscape of the biopharma sector [4][5]